Published in Headache on February 01, 1994
Refractory periods in SUNCT. J Headache Pain (2012) 0.75
Refractory periods in SUNCT. J Headache Pain (2012) 0.75
Headache in the elderly: primary forms. Neurol Sci (2010) 0.75
Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal. J Headache Pain (2017) 0.75
Impulsivity and sustained attention in pathological gamblers: influence of childhood ADHD history. J Gambl Stud (2006) 1.12
Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol Alcohol (2005) 1.03
[Prevalence of multiple sclerosis in Colombia]. Rev Neurol (2001) 1.01
Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol (1999) 0.99
Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry (2004) 0.99
Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers. Neuropsychobiology (2007) 0.97
SUNCT syndrome: duration, frequency, and temporal distribution of attacks. Headache (1996) 0.94
Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology (Berl) (1996) 0.93
Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain. Neuropsychopharmacology (2001) 0.92
Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry (2007) 0.92
Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav (1994) 0.91
The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. Eur Psychiatry (2003) 0.90
Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am J Med (1998) 0.88
The TaqIA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients. Eur Psychiatry (2005) 0.88
"Hemicrania episodica"--a new type of headache or a pre-chronic stage of hemicrania continua? Headache (1990) 0.87
Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol Psychiatry (2003) 0.87
The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in Spain. Schizophr Res (2011) 0.86
DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: association and interaction study. Br J Psychiatry (2008) 0.86
Treatment of tardive dyskinesia with aripiprazole. Neurotox Res (2009) 0.85
Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol Alcohol (2001) 0.85
The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine. Neurotox Res (2010) 0.85
The toxic shock syndrome and Staphylococcus lugdunensis bacteremia. Ann Intern Med (1998) 0.84
High frequency of childhood ADHD history in women with fibromyalgia. Eur Psychiatry (2010) 0.81
Bilateral non-simultaneous optic neuropathy and unilateral macular edema in a patient with POEMS syndrome. Eur J Ophthalmol (2009) 0.81
C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients. Acta Psychiatr Scand (2006) 0.81
The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming. Genes Brain Behav (2009) 0.81
[Validation in the adult Spanish population of the Wender Utah Rating Scale for the retrospective evaluation in adults of attention deficit/hyperactivity disorder in childhood]. Rev Neurol (2001) 0.80
Pulmonary perivascular and interstitial inflammation in MRL/MpJ-lpr/lpr mice. III. Modulation by cyclophosphamide and sex hormones in 4- and 6-month-old animals. Clin Immunol Immunopathol (1991) 0.80
Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.80
Marked hypofrontality in clozapine-responsive patients. Pharmacopsychiatry (2007) 0.80
Cerebral metabolism and risperidone treatment in schizophrenia. Schizophr Res (2003) 0.79
Premature luteal regression in goats superovulated with PMSG: effect of hCG or GnRH administration during the early luteal phase. Theriogenology (1998) 0.79
P300 amplitude as a possible correlate of frontal degeneration in schizophrenia. Schizophr Res (2001) 0.78
Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13). Genes Brain Behav (2008) 0.78
Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice. J Neural Transm (Vienna) (1999) 0.77
Cryopreservation of murine embryos, human spermatozoa and embryonic stem cells using a liquid nitrogen-free, controlled rate freezer. Reprod Biomed Online (2006) 0.77
Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry (1981) 0.77
Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis. Psychopathology (2007) 0.77
Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry (2007) 0.76
Incidence and lifetime risk of dementia and Alzheimer's disease in a Southern European population. Acta Psychiatr Scand (2011) 0.76
SUNCT syndrome. Statuslike pattern. Headache (1997) 0.76
Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists. J Neural Transm (Vienna) (1999) 0.76
Hemicrania continua. The first Spanish case: a case report. Cephalalgia (1990) 0.75
Restorative effects of glutamate antagonists in experimental parkinsonism. Amino Acids (2002) 0.75
Drug induced supersensitivity and choline acetyltransferase (ChA) activity in the rat striatum [proceedings]. Br J Pharmacol (1978) 0.75
Iris melanocytoma mimicking the Cogan-Reese syndrome with monocular pigment dissemination. Eur J Ophthalmol (2006) 0.75
Chronic paroxysmal hemicrania coexisting with migraine. Differential response to pharmacological treatment. Headache (1992) 0.75
IDRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients. Neurotox Res (2004) 0.75
A model to test the relative potencies of phosphodiesterase inhibitors in brain (in vivo) [proceedings]. Br J Pharmacol (1977) 0.75
[Oxcarbazepine in the prevention of epileptic syndromes in alcohol detoxification]. Rev Neurol (2005) 0.75
Temporal minor slow and sharp EEG activity and cerebrovascular disorder. Clin Electroencephalogr (1987) 0.75
Iris melanocytoma mimicking the Cogan-Reese syndrome with monocular pigment dissemination. Eur J Ophthalmol (2017) 0.75
Mitotic activity of the endothelial vascular cell in the immature retina. Ophthalmic Res (1988) 0.75
[Persistent corneal defects treated with botulinum toxin-induced ptosis]. Arch Soc Esp Oftalmol (2007) 0.75
Neuroprotective and neurorestorative strategies for neuronal injury. Neurotox Res (2000) 0.75
Ultrastructural study of a retinoma by intraocular fine-needle aspiration biopsy. Ophthalmologica (1988) 0.75
[Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders]. Actas Esp Psiquiatr (2007) 0.75
Differential relationships between set-shifting abilities and dimensions of insight in schizophrenia. Psychopathology (2013) 0.75
[OP.4A.10] RENAL DENERVATION VERSUS SPIRONOLACTONE IN RESISTANT HYPERTENSION. EFFECTS ON CIRCADIAN PATTERNS AND BLOOD PRESSURE VARIABILITY. J Hypertens (2016) 0.75
Neonatal nicotine administration influences ethanol-induced behaviors. Alcohol (2000) 0.75
[Eclampsia as cause of seizure in a 12 year-old girl]. An Pediatr (Barc) (2011) 0.75
[Cyclosporin-related coma in bone marrow transplantation]. Sangre (Barc) (1992) 0.75
Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa. Behav Pharmacol (2000) 0.75
[Executive dysfunctions in adults with attention deficit hyperactivity disorder]. Rev Neurol (2006) 0.75
Neurotoxicity and substance abuse: further fuel for regulatory dilemma. Neurotox Res (2001) 0.75
[Chronic pericardial effusion due to Toxoplasma gondii in a patient with a myelodysplastic syndrome]. Rev Clin Esp (1990) 0.75
[Depressive disorder and craniopharyngioma]. Rev Neurol (2003) 0.75
[Acute retinal necrosis syndrome following chickenpox]. Arch Soc Esp Oftalmol (2007) 0.75
[Efficacy of naltrexone in the treatment of alcohol dependence disorder in women]. Actas Esp Psiquiatr (2005) 0.75